• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,927.61 57.71
(0.11%)
Dow Jones
7,374.18 -5.04
(-0.07%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,536.79 75.16
(0.72%)
Forex
USD-INR
94.55 -0.19
(-0.20%)
EUR-INR
107.36 -0.64
(-0.59%)
GBP-INR
124.56 -0.65
(-0.52%)
JPY-INR
0.58 0.00
(-0.30%)

EQUITY - MARKET SCREENER

Sanofi India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500674
INE058A01010
325.3278333
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANOFI
23.54
7739.35
EPS(TTM)
Face Value()
Div & Yield %
142.76
10
3.66
 

tanla platforms ltd
Piramal Pharma reports consolidated net loss of Rs 8.83 crore in the March 2026 quarter
Apr 29,2026
Net loss of Piramal Pharma reported to Rs 8.83 crore in the quarter ended March 2026 as against net profit of Rs 153.50 crore during the previous quarter ended March 2025. Sales declined 0.08% to Rs 2751.77 crore in the quarter ended March 2026 as against Rs 2754.07 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 325.94 crore in the year ended March 2026 as against net profit of Rs 91.13 crore during the previous year ended March 2025. Sales declined 3.08% to Rs 8869.08 crore in the year ended March 2026 as against Rs 9151.18 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2751.772754.07 0 8869.089151.18 -3
OPM %16.7420.37 -10.3915.79 -
PBDT437.15515.56 -15 851.321230.98 -31
PBT218.77272.80 -20 20.08414.64 -95
NP-8.83153.50 PL -325.9491.13 PL